Additionally, the expression of αSMA was found to be correlated with poor prognosis in patients with ER positive breast cancer [96] and in patients with luminal breast cancer [97], likely mediated by a TMX resistance and an increased proliferation. This evidence concerns the gene TMX1 and breast cancer.